Level Bio ABNGM: LEVBIO

LEVBIO: Platform upgrades, Q4 pilot, and lab partnerships drive ongoing business development

· Issued by Level Bio AB

Platform enhancements and new business initiatives are underway, including a Q4 pilot and lab partnerships. Key metrics such as 70% and 46% were mentioned, with ongoing capital allocation and business development efforts.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

Level Bio AB on 6ix

Earlier from Level Bio

Later from Level Bio

All Level Bio news releases